HopeStage
Back to all studies
RecruitingNCT00018057

Brain and clinical features of anxiety in children and teens

About this titleRead the official source — NCT00018057
Medication studyAges 8–65United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 8 years to 65 years.

Listed locations
Bethesda and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 2, 2001
Recruitment status
Recruiting
Enrollment listed in the registry
3,500
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 8 Years to 65 Years
Official registry ID
NCT00018057
Official title
Show the full official title

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Recruitment & locations

Currently recruiting

Bethesda · College Park

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Does this study involve medication?

Yes. The study involves medication, including Fluoxetine.

Who can participate?

Listed age limits: 8 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies